Protocatechuic Acid: Inhibition of Fibril Formation, Destabilization of Preformed Fibrils of Amyloid-β and α-Synuclein, and Neuroprotection

被引:70
|
作者
Hornedo-Ortega, Ruth [1 ]
Antonia Alvarez-Fernandez, Maria [1 ]
Belen Cerezo, Ana [1 ]
Richard, Tristan [2 ]
Maria Troncoso, Ana [1 ]
Carmen Garcia-Parrilla, Maria [1 ]
机构
[1] Univ Seville, Fac Pharm, Area Nutr & Food Sci, C-P Garcia Gonzalez 2, E-41012 Seville, Spain
[2] Univ Bordeaux, ISVV Bordeaux Aquitaine, 71 Ave Edouard Bourleaux, F-33883 Villenave Dornon, France
关键词
neurodegeneration; toxicity; protocatechuic acid; amyloid-beta; alpha-synuclein; CYANIDIN; 3-O-GLUCOPYRANOSIDE; IN-VITRO; ANTHOCYANINS; METABOLISM; ABSORPTION; PHARMACOKINETICS; CONSUMPTION; PHENOLICS; PROTECTS;
D O I
10.1021/acs.jafc.6b03217
中图分类号
S [农业科学];
学科分类号
09 ;
摘要
Protocatechuic acid (PCA) is the major metabolite of the anthocyanin known as cyanidin 3-glucoside. It is found in plasma and tissues, such as the brain, heart, liver, and kidneys, following consumption of a rich source of this flavonoid. The abnormal pathological assembly of amyloid-beta (A beta) and alpha-synuclein (alpha S) is an underlying mechanism involved in the formation of amyloid plaques and Lewy bodies in the brain, which are responsible for neuropathology symptoms in Alzheimer's (AD) and Parkinson's diseases (PD), respectively. This research was performed to evaluate the protective effects of PCA, by establishing its potential role in inhibiting aggregation and fibril destabilization of A beta and alpha S proteins. It has been found that PCA inhibits the aggregation of A beta and alpha S and destabilizes their preformed fibrils. These results were confirmed by TEM images, electrophoresis, and immunoblotting experiments. Furthermore, PCA prevents the death of PC12 cells triggered by A beta- and alpha S-induced toxicity.
引用
收藏
页码:7722 / 7732
页数:11
相关论文
共 50 条
  • [41] Inhibition of amyloid fibril formation of human amylin
    Rijkers, DTS
    Höppener, JWM
    Posthuma, G
    Lips, CJM
    Liskamp, RMJ
    BIOPOLYMERS, 2003, 71 (03) : 324 - 324
  • [42] True and apparent inhibition of amyloid fibril formation
    Martins, Pedro M.
    PRION, 2013, 7 (02) : 136 - 139
  • [43] Bioactive polyphenol interactions with β amyloid: a comparison of binding, fibril inhibition and neuroprotection
    Smid, S.
    Das, S.
    Musgrave, I.
    Pukala, T.
    JOURNAL OF NEUROCHEMISTRY, 2015, 134 : 363 - 364
  • [44] Fibril formation by amyloid-β proteins may involve β-helical protofibrils
    Lazo, ND
    Downing, DT
    JOURNAL OF PEPTIDE RESEARCH, 1999, 53 (06): : 633 - 640
  • [45] A Mobile Precursor Determines Amyloid-β Peptide Fibril Formation at Interfaces
    Shen, Lei
    Adachi, Takuji
    Vanden Bout, David
    Zhu, X. -Y.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2012, 134 (34) : 14172 - 14178
  • [46] Analysis of fibril formation of amyloid-β-protein by stretched exponential function
    Shinozaki, K
    Konakahara, T
    Okuno, H
    Kodaka, M
    PROTEIN AND PEPTIDE LETTERS, 2003, 10 (06): : 569 - 574
  • [47] A mobile precursor determines amyloid-β peptide fibril formation at interfaces
    Zhu, X.-Y. (zhu@cm.utexas.edu), 1600, American Chemical Society (134):
  • [48] Amyloid-β fibril formation is not necessarily required for microglial activation by the peptides
    Hashioka, S
    Monji, A
    Ueda, T
    Kanba, S
    Nakanishi, H
    NEUROCHEMISTRY INTERNATIONAL, 2005, 47 (05) : 369 - 376
  • [49] Inhibition of amyloid fibril formation of lysozyme by ascorbic acid and a probable mechanism of action
    Patel, Palak
    Parmar, Krupali
    Patel, Dhaval
    Kumar, Suresh
    Trivedi, Manan
    Das, Mill
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2018, 114 : 666 - 678
  • [50] Drastic Effects on Fibril Formation of Amyloid-β Peptides by the Addition of Amino Acid Residue Units to the Termini
    Asanomi, Yuya
    Kobayashi, Yumiko
    Sakai, Hiroki
    Masuda, Takuya
    Chen, Xinjiang
    Chuman, Yoshiro
    Uosaki, Kohei
    Sakaguchi, Kazuyasu
    PROTEIN AND PEPTIDE LETTERS, 2010, 17 (04): : 458 - 463